---
title: "EPHA2 and EPHB4 in Brain Tumors and Preclinical Activity of EPHRIN-B2 CAR-T Cells"
id: "pubmed-43068431"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-43068431"
content_type: "clinical_feed_article"
specialty: "Oncology"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/43068431/"
doi: "10.1007/s11060-026-05884-x"
published_at: "2026-11-22T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# EPHA2 and EPHB4 in Brain Tumors and Preclinical Activity of EPHRIN-B2 CAR-T Cells
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-43068431
- **Specialty:** [Oncology](https://medichelpline.com/clinical-feed/oncology.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/43068431/)
- **DOI:** [10.1007/s11060-026-05884-x](https://doi.org/10.1007%2Fs11060-026-05884-x)
- **Published At:** 2026-11-22T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- The study mapped **EPHA2** and **EPHB4** protein expression by immunohistochemistry in 141 specimens from 116 patients; 113 specimens were analyzed by histological category. - **EPHA2** staining appeared across tumor types; **EPHB4** staining skewed toward higher-grade lesions. - Within glioblastoma/gliosarcoma samples, investigators reported staining scores ≥2 in 74% for **EPHA2** and 37% for **EPHB4**. - Co-expression of both receptors at high levels was concentrated in high-grade tumors, according to the authors. - The team engineered **EPHRIN-B2**-based **CAR-T** cells using the piggyBac transposon system; the source did not provide detailed transposon dosing or manufacturing parameters. - In vitro, CAR-T cells decreased viable tumor cell counts and raised interferon-γ and interleukin-2 secretion against six brain tumor cell lines; no activity difference was seen against a receptor-negative control line. - Two intracranial xenograft models received intracerebroventricular CAR-T administration; comparisons included mock T cells, control CAR-T, and phosphate-buffered saline. - Investigators observed reductions in tumor signal for EPHRIN-B2 CAR-T relative to saline at selected time points, but differences from control T cells did not reach statistical significance. - The authors concluded these data define receptor distribution in human brain tumors and show in vitro antitumor activity, supporting further preclinical work to establish CAR-specific intracranial efficacy.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/43068431/#article-details) ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43068431%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/43068431/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/43068431/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/43068431/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/a447896c-976f-490b-b86b-2668b65114a8/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/43068431/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/43068431/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/43068431/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43068431%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43068431%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/43068431/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43068431/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43068431/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/43068431/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43068431/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Experimental Resource Linked Discoveries ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/43068431/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/43068431/#abstract) * [ Conflict of interest statement ](https://pubmed.ncbi.nlm.nih.gov/43068431/#conflict-of-interest) * [ References ](https://pubmed.ncbi.nlm.nih.gov/43068431/#references) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/43068431/#mesh-terms) * [ Substances ](https://pubmed.ncbi.nlm.nih.gov/43068431/#substances) * [ Grants and funding ](https://pubmed.ncbi.nlm.nih.gov/43068431/#grants) Title & authors Abstract Conflict of interest statement References MeSH terms Substances Grants and funding J Neurooncol Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22J+Neurooncol%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22J+Neurooncol%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43068431/) . 2026 Nov 22;180(3):66. doi: 10.1007/s11060-026-05884-x. # EPHA2 and EPHB4 expression in human brain tumors and preclinical evaluation of EPHRIN-B2-based CAR-T cells [Yu Furui](https://pubmed.ncbi.nlm.nih.gov/?term=Furui+Y&cauthor_id=43068431)[#](https://pubmed.ncbi.nlm.nih.gov/43068431/#full-view-equal-contrib-explanation "Contributed equally")[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43068431/#full-view-affiliation-1 "Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan."), [Kotaro Morita](https://pubmed.ncbi.nlm.nih.gov/?term=Morita+K&cauthor_id=43068431)[#](https://pubmed.ncbi.nlm.nih.gov/43068431/#full-view-equal-contrib-explanation "Contributed equally")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43068431/#full-view-affiliation-2 "Department of Pediatric Surgery, St. Marianna University School of Medicine, Kawasaki, Japan."), [Koichi Hirabayashi](https://pubmed.ncbi.nlm.nih.gov/?term=Hirabayashi+K&cauthor_id=43068431)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43068431/#full-view-affiliation-1 "Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan."), [Marina Fujioka](https://pubmed.ncbi.nlm.nih.gov/?term=Fujioka+M&cauthor_id=43068431)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/43068431/#full-view-affiliation-3 "Department of Obstetrics and Gynecology, Shinshu University School of Medicine, Matsumoto, Japan."), [Hirotaka Kumeda](https://pubmed.ncbi.nlm.nih.gov/?term=Kumeda+H&cauthor_id=43068431)[ 4 ](https://pubmed.ncbi.nlm.nih.gov/43068431/#full-view-affiliation-4 "Division of General Thoracic Surgery, Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan."), [Yoshinori Sato](https://pubmed.ncbi.nlm.nih.gov/?term=Sato+Y&cauthor_id=43068431)[ 5 ](https://pubmed.ncbi.nlm.nih.gov/43068431/#full-view-affiliation-5 "Department of Laboratory Medicine, Shinshu University Hospital, Matsumoto, Japan."), [Takeshi Uehara](https://pubmed.ncbi.nlm.nih.gov/?term=Uehara+T&cauthor_id=43068431)[ 5 ](https://pubmed.ncbi.nlm.nih.gov/43068431/#full-view-affiliation-5 "Department of Laboratory Medicine, Shinshu University Hospital, Matsumoto, Japan."), [Yu Fujii](https://pubmed.ncbi.nlm.nih.gov/?term=Fujii+Y&cauthor_id=43068431)[ 6 ](https://pubmed.ncbi.nlm.nih.gov/43068431/#full-view-affiliation-6 "Department of Neurosurgery, Shinshu University School of Medicine, Matsumoto, Japan."), [Miyuki Tanaka](https://pubmed.ncbi.nlm.nih.gov/?term=Tanaka+M&cauthor_id=43068431)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43068431/#full-view-affiliation-1 "Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan.")[ 7 ](https://pubmed.ncbi.nlm.nih.gov/43068431/#full-view-affiliation-7 "Center for Advanced Research of Gene and Cell Therapy, Innovative Research & Liaison Organization, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan."), [Yozo Nakazawa](https://pubmed.ncbi.nlm.nih.gov/?term=Nakazawa+Y&cauthor_id=43068431)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43068431/#full-view-affiliation-1 "Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan.")[ 7 ](https://pubmed.ncbi.nlm.nih.gov/43068431/#full-view-affiliation-7 "Center for Advanced Research of Gene and Cell Therapy, Innovative Research & Liaison Organization, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan."), [Shigeki Yagyu](https://pubmed.ncbi.nlm.nih.gov/?term=Yagyu+S&cauthor_id=43068431)[ 8 ](https://pubmed.ncbi.nlm.nih.gov/43068431/#full-view-affiliation-8 "Center for Advanced Research of Gene and Cell Therapy, Innovative Research & Liaison Organization, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan. shigeky@shinshu-u.ac.jp.")[ 9 ](https://pubmed.ncbi.nlm.nih.gov/43068431/#full-view-affiliation-9 "Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan. shigeky@shinshu-u.ac.jp.") Affiliations Expand ### Affiliations * 1 Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan. * 2 Department of Pediatric Surgery, St. Marianna University School of Medicine, Kawasaki, Japan. * 3 Department of Obstetrics and Gynecology, Shinshu University School of Medicine, Matsumoto, Japan. * 4 Division of General Thoracic Surgery, Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan. * 5 Department of Laboratory Medicine, Shinshu University Hospital, Matsumoto, Japan. * 6 Department of Neurosurgery, Shinshu University School of Medicine, Matsumoto, Japan. * 7 Center for Advanced Research of Gene and Cell Therapy, Innovative Research & Liaison Organization, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan. * 8 Center for Advanced Research of Gene and Cell Therapy, Innovative Research & Liaison Organization, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan. shigeky@shinshu-u.ac.jp. * 9 Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan. shigeky@shinshu-u.ac.jp. # Contributed equally. * PMID: **43068431** * DOI: [ 10.1007/s11060-026-05884-x ](https://doi.org/10.1007/s11060-026-05884-x) Item in Clipboard # EPHA2 and EPHB4 expression in human brain tumors and preclinical evaluation of EPHRIN-B2-based CAR-T cells Yu Furui et al. J Neurooncol. 2026. Show details Display options Display options Format Abstract PubMed PMID J Neurooncol Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22J+Neurooncol%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22J+Neurooncol%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43068431/) . 2026 Nov 22;180(3):66. doi: 10.1007/s11060-026-05884-x. ### Authors [Yu Furui](https://pubmed.ncbi.nlm.nih.gov/?term=Furui+Y&cauthor_id=43068431)[#](https://pubmed.ncbi.nlm.nih.gov/43068431/#short-view-equal-contrib-explanation "Contributed equally")[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43068431/#short-view-affiliation-1 "Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan."), [Kotaro Morita](https://pubmed.ncbi.nlm.nih.gov/?term=Morita+K&cauthor_id=43068431)[#](https://pubmed.ncbi.nlm.nih.gov/43068431/#short-view-equal-contrib-explanation "Contributed equally")[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43068431/#short-view-affiliation-2 "Department of Pediatric Surgery, St. Marianna University School of Medicine, Kawasaki, Japan."), [Koichi Hirabayashi](https://pubmed.ncbi.nlm.nih.gov/?term=Hirabayashi+K&cauthor_id=43068431)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43068431/#short-view-affiliation-1 "Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan."), [Marina Fujioka](https://pubmed.ncbi.nlm.nih.gov/?term=Fujioka+M&cauthor_id=43068431)[ 3 ](https://pubmed.ncbi.nlm.nih.gov/43068431/#short-view-affiliation-3 "Department of Obstetrics and Gynecology, Shinshu University School of Medicine, Matsumoto, Japan."), [Hirotaka Kumeda](https://pubmed.ncbi.nlm.nih.gov/?term=Kumeda+H&cauthor_id=43068431)[ 4 ](https://pubmed.ncbi.nlm.nih.gov/43068431/#short-view-affiliation-4 "Division of General Thoracic Surgery, Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan."), [Yoshinori Sato](https://pubmed.ncbi.nlm.nih.gov/?term=Sato+Y&cauthor_id=43068431)[ 5 ](https://pubmed.ncbi.nlm.nih.gov/43068431/#short-view-affiliation-5 "Department of Laboratory Medicine, Shinshu University Hospital, Matsumoto, Japan."), [Takeshi Uehara](https://pubmed.ncbi.nlm.nih.gov/?term=Uehara+T&cauthor_id=43068431)[ 5 ](https://pubmed.ncbi.nlm.nih.gov/43068431/#short-view-affiliation-5 "Department of Laboratory Medicine, Shinshu University Hospital, Matsumoto, Japan."), [Yu Fujii](https://pubmed.ncbi.nlm.nih.gov/?term=Fujii+Y&cauthor_id=43068431)[ 6 ](https://pubmed.ncbi.nlm.nih.gov/43068431/#short-view-affiliation-6 "Department of Neurosurgery, Shinshu University School of Medicine, Matsumoto, Japan."), [Miyuki Tanaka](https://pubmed.ncbi.nlm.nih.gov/?term=Tanaka+M&cauthor_id=43068431)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43068431/#short-view-affiliation-1 "Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan.")[ 7 ](https://pubmed.ncbi.nlm.nih.gov/43068431/#short-view-affiliation-7 "Center for Advanced Research of Gene and Cell Therapy, Innovative Research & Liaison Organization, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan."), [Yozo Nakazawa](https://pubmed.ncbi.nlm.nih.gov/?term=Nakazawa+Y&cauthor_id=43068431)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43068431/#short-view-affiliation-1 "Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan.")[ 7 ](https://pubmed.ncbi.nlm.nih.gov/43068431/#short-view-affiliation-7 "Center for Advanced Research of Gene and Cell Therapy, Innovative Research & Liaison Organization, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan."), [Shigeki Yagyu](https://pubmed.ncbi.nlm.nih.gov/?term=Yagyu+S&cauthor_id=43068431)[ 8 ](https://pubmed.ncbi.nlm.nih.gov/43068431/#short-view-affiliation-8 "Center for Advanced Research of Gene and Cell Therapy, Innovative Research & Liaison Organization, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan. shigeky@shinshu-u.ac.jp.")[ 9 ](https://pubmed.ncbi.nlm.nih.gov/43068431/#short-view-affiliation-9 "Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan. shigeky@shinshu-u.ac.jp.") ### Affiliations * 1 Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan. * 2 Department of Pediatric Surgery, St. Marianna University School of Medicine, Kawasaki, Japan. * 3 Department of Obstetrics and Gynecology, Shinshu University School of Medicine, Matsumoto, Japan. * 4 Division of General Thoracic Surgery, Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan. * 5 Department of Laboratory Medicine, Shinshu University Hospital, Matsumoto, Japan. * 6 Department of Neurosurgery, Shinshu University School of Medicine, Matsumoto, Japan. * 7 Center for Advanced Research of Gene and Cell Therapy, Innovative Research & Liaison Organization, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan. * 8 Center for Advanced Research of Gene and Cell Therapy, Innovative Research & Liaison Organization, Shinshu University, 3-1-1 Asahi, Matsumoto, Nagano, 390-8621, Japan. shigeky@shinshu-u.ac.jp. * 9 Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan. shigeky@shinshu-u.ac.jp. # Contributed equally. * PMID: **43068431** * DOI: [ 10.1007/s11060-026-05884-x ](https://doi.org/10.1007/s11060-026-05884-x) Item in Clipboard Cite Display options Display options Format Abstract PubMed PMID Linked Discoveries ## Abstract **Purpose:** To characterize EPHA2 and EPHB4 expression in human brain tumors and evaluate the preclinical antitumor activity of EPHRIN-B2-based chimeric antigen receptor (CAR)-T cells. **Methods:** EPHA2 and EPHB4 expression was assessed by immunohistochemistry in 141 specimens from 116 patients; 113 specimens were included in analyses by histological category. EPHRIN-B2-based CAR-T cells were generated using the piggyBac transposon system. In vitro activity was evaluated against six brain tumor cell lines and a receptor-negative control line. Intracerebroventricular administration was assessed in two intracranial xenograft models, with mock T cells, control CAR-T cells, and phosphate-buffered saline as comparators. **Results:** EPHA2 expression was observed across histological categories, whereas higher EPHB4 expression was predominantly found in high-grade tumors. Among glioblastoma/gliosarcoma specimens, 74% and 37% had staining scores ≥ 2 for EPHA2 and EPHB4, respectively. High expression of both receptors within the same specimen was concentrated in high-grade tumors. CAR-T cells reduced viable tumor cell numbers and increased interferon-γ and interleukin-2 secretion against all six brain tumor cell lines, whereas no significant differences were detected with the receptor-negative control. Although differences from control T cells did not reach statistical significance, EPHRIN-B2-based CAR-T cells reduced tumor signals relative to saline-treated controls at selected time points in both xenograft models. **Conclusion:** These findings characterize EPHA2 and EPHB4 expression in human brain tumors and demonstrate in vitro antitumor activity of EPHRIN-B2-based CAR-T cells, providing a basis for further studies to establish CAR-specific efficacy in intracranial tumors. REGISTRY AND THE REGISTRATION NO. **Of the study/trial:** N/A. **Keywords:** Brain tumors; Chimeric antigen receptor T cells; EPHA2; EPHB4; EPHRIN-B2; Glioblastoma. © 2026. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature. [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## Conflict of interest statement Declarations. Ethical approval: Approval of the research protocol by an Institutional Review Board: This study was approved by the Institutional Review Board of Shinshu University School of Medicine (approval numbers: 4024, 4816, and 20–046_3). This study was performed in accordance with the Declaration of Helsinki. Consent to participate: The acquisition of immunostaining and clinical data using previously obtained surgical samples was exempt from individual consent through general consent and opt-out opportunities. All PBMC donors provided written informed consent prior to blood sample collection. Consent for publication: Not applicable. Animal studies: All animal experiments and procedures were approved by the Institution
## Related Clinical Research

- [High GPX4 Expression Defines an Oxidative-Metabolic, PD-L1/CD47-Low Tumor State in Hepatocellular](https://medichelpline.com/clinical-feed/biorxiv-0-high-gpx4-expression-marks-an-oxidative-metabolic-pd-l1-cd47-low-and-stroma.md)
- [Anxiety-related distress and quality of life during chemotherapy: a dynamic network analysis](https://medichelpline.com/clinical-feed/pubmed-43068405.md) (DOI: 10.1007/s11136-026-04445-z)
- [MDK upregulation via WTAP/m6A/YTHDF1 promotes metastasis in clear cell renal cell carcinoma](https://medichelpline.com/clinical-feed/pubmed-43067604.md) (DOI: 10.1186/s43556-026-00665-4)
- [Eukaryotic pol ζ/Rev1 complex drives CG-to-GC transversions and large mutator effect](https://medichelpline.com/clinical-feed/biorxiv-1-minimal-eukaryotic-dna-polymerase-zeta-rev1-gc-pair-mutasome.md)
- [Early STAT+ Results for Alterome’s KRAS Inhibitor in Pancreatic, Lung, and Colorectal Cancer](https://medichelpline.com/clinical-feed/stat-news-1-stat-early-results-for-alterome-s-kras-drug-for-pancreas-lung-and-colon-cancer.md)

## Navigation
- [← Back to Oncology Feed](https://medichelpline.com/clinical-feed/oncology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.